Matt represents public and private companies and investors in a range of transactional and corporate matters, with a focus on mergers and acquisitions, capital markets transactions, securities law compliance and general corporate representation. His experience includes advising clients in strategic acquisitions and divestitures, including private equity transactions, carve-out transactions and complex earn-out arrangements, as well as representing closely-held companies in exit transactions. He also advises issuers in capital markets transactions, including initial public offerings and follow-on offerings. Matt has experience counseling clients in a number of industries, including life sciences, medical technology, telecommunications, technology and retail.
During law school, he served as Articles Editor of the Suffolk University Law Review.
Experience
Mergers & Acquisitions
- Syncona Limited (LON: SYNC) in its acquisition of Applied Genetic Technologies Corporation (Nasdaq: AGTC)
- HouseWorks, a home health care provider, in connection with a majority equity investment by InTandem Capital Partners
- Philips Healthcare in connection with numerous mergers and acquisitions and other strategic transactions. Representative transactions include:
- Divestiture of Philips’ Aging and Caregiving (ACG) business
- Acquisition of Vesper Medical, Inc., a medical technology company that develops minimally-invasive peripheral vascular devices
- Acquisition of Intact Vascular, the maker of the Tack specialized implantable device for treating peripheral artery disease
- Acquisition of the teleradiology platform of Direct Radiology
- Acquisition of EPD Solutions, the innovator of a breakthrough cardiac imaging and navigation system
- Acquisition of Remote Diagnostics Technologies, a UK-based innovator of advanced solutions for the pre-hospital market providing monitoring, cardiac therapy and data management
- Acquisition of Blue Willow Systems, a cloud-based senior living community resident safety platform
- Acquisition of CardioProlific, a company developing catheter-based thrombectomy approaches to peripheral vascular disease
- Netsmart Technologies, a leading provider of healthcare Software as a Service (SaaS) technology and services solutions, in connection with numerous merger and acquisitions. Representative transactions include:
- Acquisition of Remarkable Health, an industry-leading provider of artificial intelligence technology and software solutions for behavioral health, substance use and human services organizations
- Acquisition of the entity owning TheraOffice, an industry-leading practice management platform for physical therapy and rehabilitation practices
- Acquisition of SimpleLTC, a data analytics and consulting services firm
- Acquisition of GPM, a Software-as-a-Service technology and services company
- Acquisition of Tellus, a provider of electronic visit verification (EVV), mobile care delivery and claims processing technology
- Acquisition of Quality In Real Time (QIRT), a post-acute health care consulting firm
- Acquisition of McBee Associates, a healthcare consulting firm
- Acquisition of Homecare Accounting Solutions, LLC, a cloud-based software company for home care agencies
- Acquisition of Devero, Inc., a healthcare technology company specializing in home healthcare and hospice
- Acquisition of HealthMEDX, a developer of electronic medical record (EMR) solutions
- Acquisition of Trend Consulting Services, a provider of information technology outsourcing and infrastructure support services
- Acquisition of Lavender & Wyatt Systems, a provider of enterprise behavioral health electronic medical records software and technology solutions
- Viela Bio (Nasdaq:VIE) in its $3.05 billion sale to Horizon Therapeutics (Nasdaq: HZNP), ranked in Fierce Biotech’s “The Top 10 Biopharma M&A Deals in 2021”
- F-Star Therapeutics in its reverse merger with Spring Bank Pharmaceuticals (Nasdaq: SBPH)
- Cheetah Medical, a provider of noninvasive hemodynamic monitoring devices, in connection with its sale to Baxter International Inc. (NYSE:BAX)
- Patriot Energy Group, a retail electricity and natural gas management firm, in its strategic alliance with EMEX, LLC
- Belmont Instrument Corporation, a leading provider of fluid warming infusion systems, in its recapitalization transaction with Audax Private Equity
- Jacqueline's Wholesale Bakery, Inc., a leading manufacturer of frozen cookie dough for the in-store bakery and foodservice channels, in connection with its sale to Rich Product Corporation
- Molecular Templates, Inc. in its merger with Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
- Associated Home Care, a private-duty home health aide provider, in its sale to Amedisys (NASDAQ: AMED)
- Frazier Healthcare Ventures, a middle-market private equity firm, in its acquisition of a medical footware company
- SiOnyx, an image sensor and camera company specializing in low light and near infrared imaging, in its acquisition by a leading private equity firm and subsequent sale to DC Capital Partners
- Edgile, a cybersecurity consulting firm, in a minority investment transaction with a leading private equity firm
- A privately-held distributor of industrial supplies in its sale to a strategic competitor
- Essilor International, an eyewear company, in its acquisition of Costa (NASDAQ: ATX)
- FGX International, an eyewear company, in its acquisition of Stylemark
- Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its cancer medical probe business to Dilon Technologies and the sale of its x-ray fluorescence lead paint detector business to Protec
- PTC (NASDAQ: PTC) in its acquisition of Enigma Information Systems
- Ampersand Capital Partners in its acquisitions of numerous portfolio companies
- Syncona Ltd. (LSE: SYNC) in its acquisition of Freeline Therapeutics (Nasdaq: FRLN)
- Standard BioTools (Nasdaq: LAB) in its stock-for-stock merger with SomaLogic (Nasdaq: SLGC)
Securities Offerings
- Spero Therapeutics, Inc. (NASDAQ: SPRO) in its $75 million follow-on offering and its $10 million registered direct offering
- Spero Therapeutics, Inc. (NASDAQ: SPRO) in its $83.6 million initial public offering
- WAVE Life Sciences (NASDAQ: WVE) in its $102 million initial public offering
- Lamar Advertising Company (NASDAQ: LAMR) in Rule 144A debt offerings and follow-on exchange offers
- Stemline Therapeutics (NASDAQ: STML) in its $30 million initial public offering
viewpoints
Delaware Court Finds “Material Adverse Effect” Allows Buyer to Terminate Merger Agreement
October 3, 2018 | Advisory | By Dean Zioze, Matthew Tikonoff
News & Press
BOSTON – Mintz has earned top rankings in the 2023 edition of Legal 500 United States guide. The firm is recognized in 14 practice categories, and 59 individual attorneys are also recognized in the guide, some in more than one category.
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
BOSTON – Mintz represented HouseWorks, a leading home health care provider, in connection with a strategic investment from InTandem Capital, a healthcare services focused private equity firm.
Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.
Mintz Advises SiOnyx in Sale to DC Capital Partners
October 14, 2021
M&A bar gleans lessons from blowup of $4.75B pharma deal
March 4, 2019
Mintz Promotes Six Attorneys to Member
May 23, 2018
Events & Speaking
Recognition & Awards
Chambers USA: Massachusetts – Corporate/Mergers & Acquisitions (2021 – 2023)
Greater Boston Chamber of Commerce’s Boston’s Future Leaders Program (2018)
The Legal 500 United States for M&A: Middle-Market (2024)
Recent Insights
BOSTON – Mintz has earned top rankings in the 2023 edition of Legal 500 United States guide. The firm is recognized in 14 practice categories, and 59 individual attorneys are also recognized in the guide, some in more than one category.
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
